Maybe I am too cynical, but I don't expect the pharma industry to fix something that is good for the bottom line.
How much tri-therapy cost?
But he will be competing with more interesting propositions, investment-wise, in he form of subscription drugs.
Ergo, "why ?" is "probably because of money".
Maybe I am too cynical, but I don't expect the pharma industry to fix something that is good for the bottom line.
How much tri-therapy cost?